See more : Sumitomo Chemical Company, Limited (4005.T) Income Statement Analysis – Financial Results
Complete financial analysis of Colgate-Palmolive Company (CL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Colgate-Palmolive Company, a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
You may be interested
- Smart-Core Holdings Limited (2166.HK) Income Statement Analysis – Financial Results
- Vercom S.A. (VRC.WA) Income Statement Analysis – Financial Results
- IVD Medical Holding Limited (1931.HK) Income Statement Analysis – Financial Results
- Doppler S.A. (DOPPLER.AT) Income Statement Analysis – Financial Results
- KKR Acquisition Holdings I Corp. (KAHC-WT) Income Statement Analysis – Financial Results
Colgate-Palmolive Company (CL)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: https://www.colgatepalmolive.com
About Colgate-Palmolive Company
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19.46B | 17.97B | 17.42B | 16.47B | 15.69B | 15.54B | 15.45B | 15.20B | 16.03B | 17.28B | 17.42B | 17.09B | 16.73B | 15.56B | 15.33B | 15.33B | 13.79B | 12.24B | 11.40B | 10.58B | 9.90B | 9.29B | 9.43B | 9.36B | 9.12B | 8.97B | 9.06B | 8.75B | 8.36B | 7.59B | 7.14B | 7.01B | 6.06B | 5.69B | 5.04B | 4.73B | 5.65B | 4.98B | 4.52B |
| Cost of Revenue | 8.21B | 7.72B | 7.05B | 6.45B | 6.37B | 6.31B | 6.17B | 6.07B | 6.64B | 7.17B | 7.22B | 7.15B | 7.14B | 6.36B | 6.32B | 6.70B | 6.04B | 5.54B | 5.19B | 4.75B | 4.46B | 4.22B | 4.24B | 4.27B | 3.88B | 3.96B | 4.14B | 4.13B | 4.05B | 3.68B | 3.52B | 3.52B | 3.15B | 2.99B | 2.75B | 2.64B | 3.07B | 2.80B | 2.61B |
| Gross Profit | 11.25B | 10.25B | 10.38B | 10.02B | 9.33B | 9.23B | 9.28B | 9.12B | 9.40B | 10.11B | 10.20B | 9.93B | 9.59B | 9.20B | 9.01B | 8.63B | 7.75B | 6.70B | 6.21B | 5.84B | 5.45B | 5.07B | 5.19B | 5.09B | 5.23B | 5.01B | 4.92B | 4.61B | 4.31B | 3.91B | 3.62B | 3.49B | 2.91B | 2.70B | 2.29B | 2.09B | 2.58B | 2.18B | 1.92B |
| Gross Profit Ratio | 57.82% | 57.04% | 59.55% | 60.82% | 59.42% | 59.39% | 60.05% | 60.04% | 58.62% | 58.51% | 58.56% | 58.13% | 57.31% | 59.14% | 58.77% | 56.27% | 56.18% | 54.76% | 54.44% | 55.15% | 55.00% | 54.55% | 55.06% | 54.42% | 57.41% | 55.86% | 54.27% | 52.74% | 51.51% | 51.53% | 50.71% | 49.82% | 48.02% | 47.38% | 45.50% | 44.17% | 45.68% | 43.77% | 42.34% |
| Research & Development | 343.00M | 320.00M | 307.00M | 290.00M | 281.00M | 277.00M | 285.00M | 289.00M | 274.00M | 277.00M | 267.00M | 259.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 229.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 4.87B | 4.57B | 4.41B | 4.07B | 3.88B | 5.39B | 5.50B | 5.25B | 5.46B | 5.98B | 6.22B | 5.93B | 5.76B | 5.41B | 5.28B | 5.42B | 4.97B | 4.36B | 3.92B | 2.33B | 3.30B | 3.03B | 3.26B | 3.30B | 3.25B | 3.20B | 3.24B | 3.05B | 2.88B | 2.63B | 2.46B | 2.50B | 2.48B | 2.02B | 1.76B | 1.65B | 2.09B | 1.76B | 1.57B |
| Selling & Marketing | 2.37B | 2.00B | 2.00B | 1.95B | 1.69B | 1.59B | 1.57B | 1.43B | 1.49B | 1.78B | 1.89B | 1.79B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.06B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 7.24B | 6.57B | 6.41B | 6.02B | 5.58B | 5.39B | 5.50B | 5.25B | 5.46B | 5.98B | 6.22B | 5.93B | 5.76B | 5.41B | 5.28B | 5.42B | 4.97B | 4.36B | 3.92B | 3.40B | 3.30B | 3.03B | 3.26B | 3.30B | 3.25B | 3.20B | 3.24B | 3.05B | 2.88B | 2.63B | 2.46B | 2.50B | 2.48B | 2.02B | 1.76B | 1.65B | 2.09B | 1.76B | 1.57B |
| Other Expenses | 0.00 | 69.00M | 65.00M | 113.00M | 196.00M | -87.00M | 36.00M | 22.00M | 39.00M | 14.00M | 27.00M | 30.00M | -9.00M | 301.00M | 111.00M | 183.40M | 65.70M | 32.80M | 69.20M | 22.20M | -74.30M | 23.00M | 68.00M | 72.10M | 340.20M | 330.30M | 319.90M | 316.30M | 300.30M | 235.10M | 209.60M | 192.50M | 146.20M | 126.20M | 97.00M | 82.00M | 101.30M | 89.30M | 72.20M |
| Operating Expenses | 7.34B | 6.63B | 6.47B | 6.13B | 5.77B | 5.54B | 5.69B | 5.27B | 5.53B | 6.55B | 6.65B | 6.04B | 5.75B | 5.41B | 5.39B | 5.61B | 5.04B | 4.39B | 3.99B | 3.65B | 3.22B | 3.06B | 3.33B | 3.37B | 3.59B | 3.53B | 3.56B | 3.37B | 3.18B | 2.86B | 2.67B | 2.69B | 2.63B | 2.14B | 1.86B | 1.73B | 2.20B | 1.85B | 1.64B |
| Cost & Expenses | 15.47B | 14.35B | 13.52B | 12.59B | 12.14B | 11.85B | 11.87B | 11.34B | 12.16B | 13.72B | 13.86B | 13.20B | 12.89B | 11.77B | 11.71B | 12.31B | 11.08B | 9.92B | 9.18B | 8.39B | 7.68B | 7.28B | 7.57B | 7.64B | 7.48B | 7.49B | 7.70B | 7.50B | 7.23B | 6.54B | 6.19B | 6.21B | 5.78B | 5.14B | 4.60B | 4.37B | 5.26B | 4.65B | 4.25B |
| Interest Income | 55.00M | 14.00M | 17.00M | 19.00M | 47.00M | 50.00M | 51.00M | 50.00M | 107.00M | 106.00M | 125.00M | 65.00M | 7.00M | 6.00M | 11.00M | 10.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 287.00M | 167.00M | 192.00M | 183.00M | 192.00M | 193.00M | 153.00M | 149.00M | 133.00M | 130.00M | 116.00M | 80.00M | 59.00M | 59.00M | 77.00M | 105.60M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.02B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 567.00M | 545.00M | 556.00M | 539.00M | 519.00M | 511.00M | 475.00M | 443.00M | 449.00M | 442.00M | 439.00M | 425.00M | 421.00M | 376.00M | 351.00M | 347.60M | 333.90M | 328.70M | 329.30M | 327.80M | 315.50M | 296.50M | 336.20M | 337.80M | 340.20M | 330.30M | 319.90M | 316.30M | 300.30M | 235.10M | 209.60M | 192.50M | 146.20M | 126.20M | 97.00M | 82.00M | 101.30M | 89.30M | 72.20M |
| EBITDA | 4.25B | 4.13B | 4.37B | 4.33B | 4.16B | 4.17B | 4.12B | 4.33B | 3.35B | 4.11B | 4.12B | 4.38B | 4.27B | 3.87B | 3.98B | 3.46B | 3.06B | 2.55B | 2.61B | 2.50B | 2.47B | 2.31B | 2.17B | 2.08B | 1.98B | 1.81B | 1.68B | 1.56B | 1.43B | 1.28B | 1.16B | 991.10M | 427.80M | 680.90M | 532.40M | 445.50M | 485.30M | 421.60M | 349.00M |
| EBITDA Ratio | 21.82% | 27.16% | 28.87% | 26.86% | 25.95% | 27.05% | 26.30% | 28.66% | 33.72% | 23.15% | 22.93% | 25.25% | 25.47% | 26.77% | 25.88% | 21.97% | 22.35% | 22.54% | 22.93% | 24.14% | 24.93% | 24.52% | 23.17% | 21.46% | 22.52% | 20.24% | 18.80% | 18.93% | 23.35% | 18.02% | 17.30% | 14.44% | 6.49% | 11.92% | 8.62% | 9.55% | 11.64% | 7.64% | 6.55% |
| Operating Income | 3.98B | 4.34B | 4.47B | 3.89B | 3.55B | 3.69B | 3.59B | 3.84B | 2.79B | 3.56B | 3.56B | 3.89B | 3.84B | 3.79B | 3.62B | 3.02B | 2.65B | 2.16B | 2.22B | 2.12B | 2.17B | 2.01B | 1.86B | 1.72B | 1.64B | 1.48B | 1.36B | 1.25B | 1.13B | 1.05B | 954.30M | 798.60M | 281.60M | 554.70M | 435.40M | 363.50M | 384.00M | 332.30M | 276.80M |
| Operating Income Ratio | 20.48% | 24.13% | 25.68% | 23.59% | 22.65% | 23.76% | 23.22% | 25.25% | 17.39% | 20.59% | 20.41% | 22.76% | 22.95% | 24.35% | 23.59% | 19.70% | 19.24% | 17.65% | 19.44% | 20.05% | 21.87% | 21.66% | 19.74% | 18.39% | 17.98% | 16.54% | 15.00% | 14.24% | 13.47% | 13.83% | 13.36% | 11.40% | 4.65% | 9.75% | 8.64% | 7.68% | 6.80% | 6.67% | 6.12% |
| Total Other Income/Expenses | -592.00M | -233.00M | -245.00M | -238.00M | -253.00M | -230.00M | -220.00M | -99.00M | -26.00M | -24.00M | 9.00M | -118.00M | -52.00M | -59.00M | -77.00M | -15.70M | -89.50M | -158.70M | -80.70M | -151.20M | -124.10M | -142.80M | -166.10M | -173.30M | -245.20M | -234.10M | -255.90M | -291.20M | -762.00M | -169.50M | -118.10M | -70.70M | -63.70M | -43.30M | 11.50M | -113.20M | -261.20M | -35.30M | -1.30M |
| Income Before Tax | 3.39B | 2.66B | 3.09B | 3.65B | 3.30B | 3.46B | 3.49B | 3.74B | 2.76B | 3.53B | 3.57B | 3.87B | 3.79B | 3.43B | 3.54B | 2.93B | 2.50B | 2.00B | 2.08B | 2.00B | 2.04B | 1.87B | 1.67B | 1.57B | 1.39B | 1.25B | 1.10B | 954.60M | 363.50M | 879.90M | 836.20M | 727.90M | 217.90M | 511.40M | 446.90M | 250.30M | 122.80M | 297.00M | 275.50M |
| Income Before Tax Ratio | 17.43% | 14.80% | 17.72% | 22.14% | 21.03% | 22.29% | 22.56% | 24.60% | 17.23% | 20.45% | 20.46% | 22.67% | 22.64% | 22.04% | 23.08% | 19.08% | 18.10% | 16.36% | 18.24% | 18.92% | 20.62% | 20.12% | 17.70% | 16.75% | 15.29% | 13.93% | 12.17% | 10.91% | 4.35% | 11.60% | 11.71% | 10.39% | 3.60% | 8.99% | 8.87% | 5.29% | 2.17% | 5.96% | 6.09% |
| Income Tax Expense | 937.00M | 693.00M | 749.00M | 787.00M | 774.00M | 906.00M | 1.31B | 1.15B | 1.22B | 1.19B | 1.16B | 1.24B | 1.24B | 1.12B | 1.14B | 967.90M | 759.10M | 648.40M | 727.60M | 675.30M | 620.60M | 582.00M | 522.10M | 503.40M | 457.30M | 401.50M | 361.90M | 319.60M | 191.50M | 299.70M | 288.10M | 250.90M | 93.00M | 190.40M | 166.90M | 97.60M | 68.80M | 119.50M | 107.70M |
| Net Income | 2.30B | 1.79B | 2.17B | 2.70B | 2.37B | 2.40B | 2.02B | 2.44B | 1.38B | 2.18B | 2.24B | 2.47B | 2.43B | 2.20B | 2.29B | 1.96B | 1.74B | 1.35B | 1.35B | 1.33B | 1.42B | 1.29B | 1.15B | 1.06B | 937.30M | 848.60M | 740.40M | 635.00M | 172.00M | 580.20M | 189.90M | 477.00M | 124.90M | 321.00M | 280.00M | 192.80M | 54.00M | 177.50M | 171.90M |
| Net Income Ratio | 11.82% | 9.93% | 12.43% | 16.36% | 15.08% | 15.44% | 13.10% | 16.06% | 8.63% | 12.62% | 12.86% | 14.47% | 14.53% | 14.15% | 14.95% | 12.77% | 12.60% | 11.06% | 11.86% | 12.54% | 14.35% | 13.86% | 12.16% | 11.37% | 10.28% | 9.46% | 8.18% | 7.26% | 2.06% | 7.65% | 2.66% | 6.81% | 2.06% | 5.64% | 5.56% | 4.07% | 0.96% | 3.56% | 3.80% |
| EPS | 2.78 | 2.13 | 2.56 | 3.15 | 2.76 | 2.76 | 2.30 | 2.74 | 1.53 | 2.38 | 2.41 | 2.60 | 2.49 | 2.23 | 2.27 | 1.91 | 1.68 | 1.29 | 1.27 | 1.23 | 1.30 | 1.17 | 1.01 | 0.91 | 0.79 | 0.70 | 0.61 | 0.53 | 0.13 | 0.48 | 0.14 | 0.37 | 0.10 | 0.28 | 0.25 | 0.18 | 0.05 | 0.16 | 0.14 |
| EPS Diluted | 2.77 | 2.13 | 2.55 | 3.14 | 2.75 | 2.75 | 2.28 | 2.72 | 1.52 | 2.36 | 2.38 | 2.58 | 2.47 | 2.15 | 2.19 | 1.83 | 1.60 | 1.23 | 1.22 | 1.17 | 1.23 | 1.10 | 0.95 | 0.85 | 0.74 | 0.65 | 0.56 | 0.49 | 0.13 | 0.45 | 0.13 | 0.35 | 0.10 | 0.27 | 0.24 | 0.18 | 0.05 | 0.16 | 0.14 |
| Weighted Avg Shares Out | 827.40M | 836.40M | 845.00M | 856.80M | 859.10M | 870.60M | 881.80M | 891.80M | 902.20M | 915.10M | 930.80M | 952.20M | 976.60M | 975.60M | 999.00M | 1.01B | 1.02B | 1.03B | 1.04B | 1.06B | 1.07B | 1.09B | 1.11B | 1.15B | 1.17B | 1.18B | 1.18B | 1.17B | 1.16B | 1.17B | 1.25B | 1.25B | 1.10B | 1.06B | 1.08B | 1.07B | 1.07B | 1.11B | 929.71M |
| Weighted Avg Shares Out (Dil) | 829.20M | 838.80M | 848.30M | 859.30M | 861.10M | 873.00M | 887.80M | 898.40M | 909.70M | 924.30M | 939.90M | 960.20M | 984.00M | 1.02B | 1.05B | 1.07B | 1.07B | 1.08B | 1.09B | 1.12B | 1.13B | 1.16B | 1.19B | 1.23B | 1.25B | 1.27B | 1.27B | 1.25B | 1.16B | 1.26B | 1.29B | 1.32B | 1.10B | 1.14B | 1.12B | 1.07B | 1.07B | 1.11B | 929.71M |
Colgate (CL) Benefits From Innovation & Pricing Actions
Colgate's (CL) margins benefit from robust pricing and funding-the-growth and other productivity initiatives.
Colgate-Palmolive Webcasts Presentation at the Barclays 2024 Global Consumer Staples Conference
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive (NYSE:CL) Chairman, President and CEO, Noel Wallace, will present on Wednesday, September 4, 2024 at 10:30 a.m. ET at the Barclays 2024 Global Consumer Staples Conference. Investors may access a live webcast of this presentation and the...
Constellation Digital Partners Founder and CEO Appointed to America's Credit Unions Business Advocate Advisory Committee
RALEIGH, N.C.--(BUSINESS WIRE)-- #creditunions--Constellation Digital Partners founder and CEO Kris Kovacs has been appointed to America's Credit Unions Business Advocate Advisory Committee.
Colgate-Palmolive: Stability Pillar Reached Its Fair Value
Colgate-Palmolive operates globally with a strong presence in over 200 countries, deriving two-thirds of revenue from non-US markets. The Company is a member of the Dividend Kings group, offering reliable dividend income, which grew consecutively for 60 years. Strong organic...
7 Defensive Stocks to Buy as Investors Seek Shelter
Although the market may have hit a calm relative to the wild volatility witnessed earlier this month, we may not be out of the woods yet. Sure, the CBOE Volatility Index or the VIX has come down significantly from its...
7 Divine Dividend Stocks to Buy for Another Market Crash
Buying dividend stocks has proven to be a superior investing strategy. Because dividend payers tend to be large, successful businesses, they can better withstand the winds of market turmoil.
7 Recession-Proof Dividend Stocks to Buy Before the Next Crash
Many people believe a recession is looming as macro indicators flash red across the board. The Sahm Rule was recently activated.
4 Consumer Staples Stocks to Buy Amid Wall Street Bloodbath
Consumer staple stocks like Colgate-Palmolive Company (CL), Kimberly-Clark Corporation (KMB), The Coca-Cola Company (KO) and Philip Morris International Inc. (PM) are a safe bet during times of market volatility.
Colgate-Palmolive: Good Growth Prospects Ahead
Colgate-Palmolive Company has good growth prospects with revenue growth expected from price increases, especially in emerging markets and Hills Pet Nutrition business. The company's margins should benefit from a favorable price/cost environment, volume leverage, and cost-saving initiatives, leading to continued...
Is Colgate-Palmolive (CL) a Solid Growth Stock? 3 Reasons to Think "Yes"
Colgate-Palmolive (CL) could produce exceptional returns because of its solid growth attributes.
Source: https://incomestatements.info
Category: Stock Reports